US Stock MarketDetailed Quotes
TNDM Tandem Diabetes Care
- 27.340
- -1.250-4.37%
Close Nov 15 16:00 ET
- 27.700
- +0.360+1.32%
Post 20:01 ET
1.80BMarket Cap-14092P/E (TTM)
28.940High27.280Low1.68MVolume28.940Open28.590Pre Close46.81MTurnover2.59%Turnover RatioLossP/E (Static)65.68MShares53.69052wk High7.55P/B1.78BFloat Cap17.33052wk Low--Dividend TTM65.11MShs Float302.500Historical High--Div YieldTTM5.81%Amplitude2.140Historical Low27.793Avg Price1Lot Size
Tandem Diabetes Care Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 31.43%243.97M | 13.27%221.91M | 13.16%191.67M | -6.68%747.72M | -10.75%196.8M | -9.25%185.62M | -2.17%195.92M | -3.71%169.38M | 14.00%801.22M | 5.00%220.5M |
| Operating revenue | 31.43%243.97M | 13.27%221.91M | 13.16%191.67M | -6.68%747.72M | -10.75%196.8M | -9.25%185.62M | -2.17%195.92M | -3.71%169.38M | 14.00%801.22M | 5.00%220.5M |
| Cost of revenue | 24.46%119.32M | 15.86%109.12M | 12.17%97M | -2.11%380.03M | -1.41%103.5M | -4.25%95.87M | -4.20%94.18M | 1.96%86.48M | 18.88%388.23M | 9.05%104.98M |
| Gross profit | 38.88%124.65M | 10.87%112.79M | 14.19%94.67M | -10.97%367.69M | -19.24%93.3M | -14.05%89.75M | -0.21%101.74M | -8.99%82.91M | 9.77%412.99M | 1.58%115.52M |
| Operating expense | 24.28%150.75M | 2.15%143.57M | -35.29%136.35M | 9.98%522.17M | -3.69%128.36M | 0.33%121.3M | 23.08%140.54M | 97.99%210.72M | 34.29%474.8M | 31.97%133.28M |
| Selling and administrative expenses | 25.60%99.64M | -3.45%94.24M | 0.33%90.11M | 5.01%352.5M | -12.22%85.75M | -5.68%79.33M | 21.08%97.61M | 22.58%89.81M | 28.36%335.68M | 36.63%97.69M |
| Research and development costs | 21.77%51.11M | 14.89%49.33M | -61.75%46.24M | 21.96%169.67M | 19.72%42.6M | 14.06%41.97M | 27.89%42.93M | 264.63%120.91M | 51.12%139.11M | 20.66%35.59M |
| Operating profit | 17.28%-26.09M | 20.70%-30.77M | 67.39%-41.68M | -149.93%-154.48M | -97.47%-35.06M | -91.45%-31.55M | -217.08%-38.81M | -733.34%-127.82M | -372.85%-61.81M | -239.39%-17.76M |
| Net non-operating interest income expense | 326.35%3.48M | -75.33%1.03M | -19.24%3.42M | 8,636.84%12.98M | 147.36%3.75M | 466.67%816K | 688.59%4.18M | 484.29%4.23M | 97.17%-152K | 197.12%1.52M |
| Non-operating interest income | -5.52%5.34M | -51.18%2.82M | -9.39%5.31M | 277.38%22.86M | 79.36%5.55M | 228.84%5.66M | 600.24%5.78M | 1,313.25%5.87M | 798.66%6.06M | 6,687.23%3.1M |
| Non-operating interest expense | -54.93%1.87M | 11.71%1.79M | 6.22%1.15M | 75.40%7.57M | 10.94%1.2M | 283.86%4.14M | 48.89%1.61M | 0.00%1.08M | 0.00%4.31M | 0.00%1.08M |
| Total other finance cost | ---- | ---- | 35.25%752K | 22.20%2.32M | 20.96%606K | 40.96%702K | ---- | 26.94%556K | 9.79%1.9M | 15.17%501K |
| Other net income (expense) | -1.27M | -154.92%-78.75M | 0 | -2,128.86%-30.89M | 487.50%124K | |||||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 110.61%147K | ---- |
| Special income (charges) | --0 | --0 | ---1.27M | -153.71%-78.75M | --0 | --0 | --0 | --0 | ---31.04M | ---23K |
| -Less:Other special charges | ---- | ---- | --1.27M | 153.71%78.75M | --0 | ---- | ---- | ---- | --31.04M | --23K |
| Income before tax | 26.41%-22.61M | 14.11%-29.74M | 68.01%-39.53M | -137.21%-220.25M | -94.30%-31.31M | 35.10%-30.73M | -167.41%-34.63M | -651.79%-123.59M | -683.94%-92.85M | -244.59%-16.11M |
| Income tax | -71.46%637K | -6.54%1.07M | 1,010.10%3.19M | 35.30%2.36M | -401.15%-1.31M | 37.69%2.23M | -45.58%1.15M | 116.65%287K | 420.00%1.74M | -177.45%-261K |
| Net income | 29.46%-23.25M | 13.87%-30.81M | 65.52%-42.72M | -135.33%-222.61M | -89.25%-30M | 32.69%-32.96M | -137.61%-35.78M | -741.81%-123.87M | -707.70%-94.59M | -246.68%-15.85M |
| Net income continuous Operations | 29.46%-23.25M | 13.87%-30.81M | 65.52%-42.72M | -135.33%-222.61M | -89.25%-30M | 32.69%-32.96M | -137.61%-35.78M | -741.81%-123.87M | -707.70%-94.59M | -246.68%-15.85M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 29.46%-23.25M | 13.87%-30.81M | 65.52%-42.72M | -135.33%-222.61M | -89.25%-30M | 32.69%-32.96M | -137.61%-35.78M | -741.81%-123.87M | -707.70%-94.59M | -246.68%-15.85M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 29.46%-23.25M | 13.87%-30.81M | 65.52%-42.72M | -135.33%-222.61M | -89.25%-30M | 32.69%-32.96M | -137.61%-35.78M | -741.81%-123.87M | -707.70%-94.59M | -246.68%-15.85M |
| Basic earnings per share | 31.37%-0.35 | 14.55%-0.47 | 66.15%-0.65 | -133.33%-3.43 | -84.00%-0.46 | 32.89%-0.51 | -139.13%-0.55 | -734.78%-1.92 | -688.00%-1.47 | -247.06%-0.25 |
| Diluted earnings per share | 31.37%-0.35 | 14.55%-0.47 | 66.15%-0.65 | -133.33%-3.43 | -84.00%-0.46 | 32.89%-0.51 | -129.17%-0.55 | -734.78%-1.92 | -712.50%-1.47 | -256.25%-0.25 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data